Changes of survivin mRNA and protein expression during paclitaxel treatment in breast cancer cells

Huihua Xiong , Shiying Yu , Liang Zhuang , Hua Xiong

Current Medical Science ›› 2007, Vol. 27 ›› Issue (19) : 65 -67.

PDF
Current Medical Science ›› 2007, Vol. 27 ›› Issue (19) : 65 -67. DOI: 10.1007/s11596-007-0119-9
Article

Changes of survivin mRNA and protein expression during paclitaxel treatment in breast cancer cells

Author information +
History +
PDF

Abstract

In order to investigate the role of antiapoptosis gene, survivin in the resistance to palcitaxel, the expression of survivin mRNA and protein in the process of paclitaxel treatment in breast cancer cell line MCF-7 was detected MCF-7 cells were incubated with paclitaxel at different concentrations. The growth inhibition rate of MCF-7 was investigated by tetrazolium bromide (MTT) colorimetry. The change of apoptosis was detected by Annexin-V/PI methods. The changes in the expression of survivin mRNA and protein were studied by reverse transcription polymerase chain reaction (RT-PCR) and Western-blot assay respectively. The growth inhibition rate of MCF-7 was increased in a concentration-and time-dependent manner. Paclitaxel of higher concentration could effectively induce apoptosis in MCF-7 cells after 48 h, while the expression of survivin was increased at early time (within 6 h) and decreased after 24 h regardless of treatment concentrations of paclitaxel. It suggested that tumor cells might evade the paclitaxel-induced cell cycle arrest and apoptosis by increasing the level of survivin at early treatment time.

Keywords

breast cancer / survivin / apoptosis / paclitaxel

Cite this article

Download citation ▾
Huihua Xiong, Shiying Yu, Liang Zhuang, Hua Xiong. Changes of survivin mRNA and protein expression during paclitaxel treatment in breast cancer cells. Current Medical Science, 2007, 27(19): 65-67 DOI:10.1007/s11596-007-0119-9

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

LiY. H., WangC., MengK., et al.. Influence of survivin and caspase-3 on cell apoptosis and prognosis in gastric carcinoma. World J Gastroenterol, 2004, 10: 1984-1988

[2]

DuttaT., SharmaH., KumarL., et al.. Neoadjuvant chemotherapy for epithelial ovarian cancer-role of apoptosis. Cancer Chemother Pharmacol, 2005, 56: 427-435

[3]

YangJ. H., ZhangY. C., QianH. Q.. Survivin antisense oligodeoxynucleotide inhibits growth of gastric cancer cells. World J Gastroenterol, 2004, 10: 1121-1124

[4]

IkeguchiM., LiuJ., KaibaraN., et al.. Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment. Apoptosis, 2002, 7: 23-29

[5]

O’ConnorD. S., WallN. R., PorterA. C., et al.. A p34 (cdc2) survival checkpoint in cancer. Cancer Cell, 2002, 2: 43-54

AI Summary AI Mindmap
PDF

82

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/